▶ 調査レポート

ポリポリメラーゼ2の世界市場(~2026年)

• 英文タイトル:Global Poly Polymerase 2 Market Insights and Forecast to 2026

QYResearchが調査・発行した産業分析レポートです。ポリポリメラーゼ2の世界市場(~2026年) / Global Poly Polymerase 2 Market Insights and Forecast to 2026 / MRC2-11QY13930資料のイメージです。• レポートコード:MRC2-11QY13930
• 出版社/出版日:QYResearch / 2020年11月30日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、114ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はポリポリメラーゼ2のグローバル市場について調査・分析したレポートです。種類別(BGB-290、AZ-0108、CK-102、NOV-1401、その他)市場規模、用途別(腹膜がん、B細胞慢性リンパ性白血病、喉頭がん、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ポリポリメラーゼ2の競争状況、市場シェア
・世界のポリポリメラーゼ2市場:種類別市場規模 2015年-2020年(BGB-290、AZ-0108、CK-102、NOV-1401、その他)
・世界のポリポリメラーゼ2市場:種類別市場規模予測 2021年-2026年(BGB-290、AZ-0108、CK-102、NOV-1401、その他)
・世界のポリポリメラーゼ2市場:用途別市場規模 2015年-2020年(腹膜がん、B細胞慢性リンパ性白血病、喉頭がん、その他)
・世界のポリポリメラーゼ2市場:用途別市場規模予測 2021年-2026年(腹膜がん、B細胞慢性リンパ性白血病、喉頭がん、その他)
・北米のポリポリメラーゼ2市場分析:米国、カナダ
・ヨーロッパのポリポリメラーゼ2市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのポリポリメラーゼ2市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のポリポリメラーゼ2市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのポリポリメラーゼ2市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):AbbVie Inc、AstraZeneca Plc、BeiGene Ltd、Clovis Oncology Inc、Eisai、Ildong Pharmaceutical Co Ltd、Jiangsu Hengrui Medicine Co Ltd、Shanghai Acebright Pharmaceuticals Group Co Ltd、Tesaro Inc
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Poly Polymerase 2 Market
The global Poly Polymerase 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Poly Polymerase 2 Scope and Market Size
Poly Polymerase 2 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Poly Polymerase 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Poly Polymerase 2 market is segmented into
BGB-290
AZ-0108
CK-102
NOV-1401
Others

Segment by Application, the Poly Polymerase 2 market is segmented into
Peritoneal Cancer
B-Cell Chronic Lymphocytic Leukemia
Laryngeal Cancer
Others

Regional and Country-level Analysis
The Poly Polymerase 2 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Poly Polymerase 2 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Poly Polymerase 2 Market Share Analysis
Poly Polymerase 2 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Poly Polymerase 2 business, the date to enter into the Poly Polymerase 2 market, Poly Polymerase 2 product introduction, recent developments, etc.

The major vendors covered:
AbbVie Inc
AstraZeneca Plc
BeiGene Ltd
Clovis Oncology Inc
Eisai
Ildong Pharmaceutical Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Shanghai Acebright Pharmaceuticals Group Co Ltd
Tesaro Inc

レポート目次

1 Study Coverage
1.1 Poly Polymerase 2 Product Introduction
1.2 Market Segments
1.3 Key Poly Polymerase 2 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Poly Polymerase 2 Market Size Growth Rate by Type
1.4.2 BGB-290
1.4.3 AZ-0108
1.4.4 CK-102
1.4.5 NOV-1401
1.4.6 Others
1.5 Market by Application
1.5.1 Global Poly Polymerase 2 Market Size Growth Rate by Application
1.5.2 Peritoneal Cancer
1.5.3 B-Cell Chronic Lymphocytic Leukemia
1.5.4 Laryngeal Cancer
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Poly Polymerase 2 Market Size, Estimates and Forecasts
2.1.1 Global Poly Polymerase 2 Revenue 2015-2026
2.1.2 Global Poly Polymerase 2 Sales 2015-2026
2.2 Global Poly Polymerase 2, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Poly Polymerase 2 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Poly Polymerase 2 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Poly Polymerase 2 Competitor Landscape by Players
3.1 Poly Polymerase 2 Sales by Manufacturers
3.1.1 Poly Polymerase 2 Sales by Manufacturers (2015-2020)
3.1.2 Poly Polymerase 2 Sales Market Share by Manufacturers (2015-2020)
3.2 Poly Polymerase 2 Revenue by Manufacturers
3.2.1 Poly Polymerase 2 Revenue by Manufacturers (2015-2020)
3.2.2 Poly Polymerase 2 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Poly Polymerase 2 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Poly Polymerase 2 Revenue in 2019
3.2.5 Global Poly Polymerase 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Poly Polymerase 2 Price by Manufacturers
3.4 Poly Polymerase 2 Manufacturing Base Distribution, Product Types
3.4.1 Poly Polymerase 2 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Poly Polymerase 2 Product Type
3.4.3 Date of International Manufacturers Enter into Poly Polymerase 2 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Poly Polymerase 2 Market Size by Type (2015-2020)
4.1.1 Global Poly Polymerase 2 Sales by Type (2015-2020)
4.1.2 Global Poly Polymerase 2 Revenue by Type (2015-2020)
4.1.3 Poly Polymerase 2 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Poly Polymerase 2 Market Size Forecast by Type (2021-2026)
4.2.1 Global Poly Polymerase 2 Sales Forecast by Type (2021-2026)
4.2.2 Global Poly Polymerase 2 Revenue Forecast by Type (2021-2026)
4.2.3 Poly Polymerase 2 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Poly Polymerase 2 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Poly Polymerase 2 Market Size by Application (2015-2020)
5.1.1 Global Poly Polymerase 2 Sales by Application (2015-2020)
5.1.2 Global Poly Polymerase 2 Revenue by Application (2015-2020)
5.1.3 Poly Polymerase 2 Price by Application (2015-2020)
5.2 Poly Polymerase 2 Market Size Forecast by Application (2021-2026)
5.2.1 Global Poly Polymerase 2 Sales Forecast by Application (2021-2026)
5.2.2 Global Poly Polymerase 2 Revenue Forecast by Application (2021-2026)
5.2.3 Global Poly Polymerase 2 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Poly Polymerase 2 by Country
6.1.1 North America Poly Polymerase 2 Sales by Country
6.1.2 North America Poly Polymerase 2 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Poly Polymerase 2 Market Facts & Figures by Type
6.3 North America Poly Polymerase 2 Market Facts & Figures by Application

7 Europe
7.1 Europe Poly Polymerase 2 by Country
7.1.1 Europe Poly Polymerase 2 Sales by Country
7.1.2 Europe Poly Polymerase 2 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Poly Polymerase 2 Market Facts & Figures by Type
7.3 Europe Poly Polymerase 2 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Poly Polymerase 2 by Region
8.1.1 Asia Pacific Poly Polymerase 2 Sales by Region
8.1.2 Asia Pacific Poly Polymerase 2 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Poly Polymerase 2 Market Facts & Figures by Type
8.3 Asia Pacific Poly Polymerase 2 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Poly Polymerase 2 by Country
9.1.1 Latin America Poly Polymerase 2 Sales by Country
9.1.2 Latin America Poly Polymerase 2 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Poly Polymerase 2 Market Facts & Figures by Type
9.3 Central & South America Poly Polymerase 2 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Poly Polymerase 2 by Country
10.1.1 Middle East and Africa Poly Polymerase 2 Sales by Country
10.1.2 Middle East and Africa Poly Polymerase 2 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Poly Polymerase 2 Market Facts & Figures by Type
10.3 Middle East and Africa Poly Polymerase 2 Market Facts & Figures by Application

11 Company Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Corporation Information
11.1.2 AbbVie Inc Description and Business Overview
11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Inc Poly Polymerase 2 Products Offered
11.1.5 AbbVie Inc Related Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Corporation Information
11.2.2 AstraZeneca Plc Description and Business Overview
11.2.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Plc Poly Polymerase 2 Products Offered
11.2.5 AstraZeneca Plc Related Developments
11.3 BeiGene Ltd
11.3.1 BeiGene Ltd Corporation Information
11.3.2 BeiGene Ltd Description and Business Overview
11.3.3 BeiGene Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 BeiGene Ltd Poly Polymerase 2 Products Offered
11.3.5 BeiGene Ltd Related Developments
11.4 Clovis Oncology Inc
11.4.1 Clovis Oncology Inc Corporation Information
11.4.2 Clovis Oncology Inc Description and Business Overview
11.4.3 Clovis Oncology Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Clovis Oncology Inc Poly Polymerase 2 Products Offered
11.4.5 Clovis Oncology Inc Related Developments
11.5 Eisai
11.5.1 Eisai Corporation Information
11.5.2 Eisai Description and Business Overview
11.5.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Eisai Poly Polymerase 2 Products Offered
11.5.5 Eisai Related Developments
11.6 Ildong Pharmaceutical Co Ltd
11.6.1 Ildong Pharmaceutical Co Ltd Corporation Information
11.6.2 Ildong Pharmaceutical Co Ltd Description and Business Overview
11.6.3 Ildong Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Ildong Pharmaceutical Co Ltd Poly Polymerase 2 Products Offered
11.6.5 Ildong Pharmaceutical Co Ltd Related Developments
11.7 Jiangsu Hengrui Medicine Co Ltd
11.7.1 Jiangsu Hengrui Medicine Co Ltd Corporation Information
11.7.2 Jiangsu Hengrui Medicine Co Ltd Description and Business Overview
11.7.3 Jiangsu Hengrui Medicine Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Jiangsu Hengrui Medicine Co Ltd Poly Polymerase 2 Products Offered
11.7.5 Jiangsu Hengrui Medicine Co Ltd Related Developments
11.8 Shanghai Acebright Pharmaceuticals Group Co Ltd
11.8.1 Shanghai Acebright Pharmaceuticals Group Co Ltd Corporation Information
11.8.2 Shanghai Acebright Pharmaceuticals Group Co Ltd Description and Business Overview
11.8.3 Shanghai Acebright Pharmaceuticals Group Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Shanghai Acebright Pharmaceuticals Group Co Ltd Poly Polymerase 2 Products Offered
11.8.5 Shanghai Acebright Pharmaceuticals Group Co Ltd Related Developments
11.9 Tesaro Inc
11.9.1 Tesaro Inc Corporation Information
11.9.2 Tesaro Inc Description and Business Overview
11.9.3 Tesaro Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Tesaro Inc Poly Polymerase 2 Products Offered
11.9.5 Tesaro Inc Related Developments
11.1 AbbVie Inc
11.1.1 AbbVie Inc Corporation Information
11.1.2 AbbVie Inc Description and Business Overview
11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Inc Poly Polymerase 2 Products Offered
11.1.5 AbbVie Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Poly Polymerase 2 Market Estimates and Projections by Region
12.1.1 Global Poly Polymerase 2 Sales Forecast by Regions 2021-2026
12.1.2 Global Poly Polymerase 2 Revenue Forecast by Regions 2021-2026
12.2 North America Poly Polymerase 2 Market Size Forecast (2021-2026)
12.2.1 North America: Poly Polymerase 2 Sales Forecast (2021-2026)
12.2.2 North America: Poly Polymerase 2 Revenue Forecast (2021-2026)
12.2.3 North America: Poly Polymerase 2 Market Size Forecast by Country (2021-2026)
12.3 Europe Poly Polymerase 2 Market Size Forecast (2021-2026)
12.3.1 Europe: Poly Polymerase 2 Sales Forecast (2021-2026)
12.3.2 Europe: Poly Polymerase 2 Revenue Forecast (2021-2026)
12.3.3 Europe: Poly Polymerase 2 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Poly Polymerase 2 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Poly Polymerase 2 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Poly Polymerase 2 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Poly Polymerase 2 Market Size Forecast by Region (2021-2026)
12.5 Latin America Poly Polymerase 2 Market Size Forecast (2021-2026)
12.5.1 Latin America: Poly Polymerase 2 Sales Forecast (2021-2026)
12.5.2 Latin America: Poly Polymerase 2 Revenue Forecast (2021-2026)
12.5.3 Latin America: Poly Polymerase 2 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Poly Polymerase 2 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Poly Polymerase 2 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Poly Polymerase 2 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Poly Polymerase 2 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Poly Polymerase 2 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Poly Polymerase 2 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Poly Polymerase 2 Market Segments
Table 2. Ranking of Global Top Poly Polymerase 2 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Poly Polymerase 2 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of BGB-290
Table 5. Major Manufacturers of AZ-0108
Table 6. Major Manufacturers of CK-102
Table 7. Major Manufacturers of NOV-1401
Table 8. Major Manufacturers of Others
Table 9. Global Poly Polymerase 2 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Poly Polymerase 2 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Poly Polymerase 2 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Poly Polymerase 2 Sales Market Share by Regions (2015-2020)
Table 13. Global Poly Polymerase 2 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Poly Polymerase 2 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Poly Polymerase 2 Sales Share by Manufacturers (2015-2020)
Table 16. Global Poly Polymerase 2 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Poly Polymerase 2 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Poly Polymerase 2 as of 2019)
Table 18. Poly Polymerase 2 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Poly Polymerase 2 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Poly Polymerase 2 Price (2015-2020) (USD/Pcs)
Table 21. Poly Polymerase 2 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Poly Polymerase 2 Product Type
Table 23. Date of International Manufacturers Enter into Poly Polymerase 2 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Poly Polymerase 2 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Poly Polymerase 2 Sales Share by Type (2015-2020)
Table 27. Global Poly Polymerase 2 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Poly Polymerase 2 Revenue Share by Type (2015-2020)
Table 29. Poly Polymerase 2 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Poly Polymerase 2 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Poly Polymerase 2 Sales Share by Application (2015-2020)
Table 32. North America Poly Polymerase 2 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Poly Polymerase 2 Sales Market Share by Country (2015-2020)
Table 34. North America Poly Polymerase 2 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Poly Polymerase 2 Revenue Market Share by Country (2015-2020)
Table 36. North America Poly Polymerase 2 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Poly Polymerase 2 Sales Market Share by Type (2015-2020)
Table 38. North America Poly Polymerase 2 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Poly Polymerase 2 Sales Market Share by Application (2015-2020)
Table 40. Europe Poly Polymerase 2 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Poly Polymerase 2 Sales Market Share by Country (2015-2020)
Table 42. Europe Poly Polymerase 2 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Poly Polymerase 2 Revenue Market Share by Country (2015-2020)
Table 44. Europe Poly Polymerase 2 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Poly Polymerase 2 Sales Market Share by Type (2015-2020)
Table 46. Europe Poly Polymerase 2 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Poly Polymerase 2 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Poly Polymerase 2 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Poly Polymerase 2 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Poly Polymerase 2 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Poly Polymerase 2 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Poly Polymerase 2 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Poly Polymerase 2 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Poly Polymerase 2 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Poly Polymerase 2 Sales Market Share by Application (2015-2020)
Table 56. Latin America Poly Polymerase 2 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Poly Polymerase 2 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Poly Polymerase 2 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Poly Polymerase 2 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Poly Polymerase 2 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Poly Polymerase 2 Sales Market Share by Type (2015-2020)
Table 62. Latin America Poly Polymerase 2 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Poly Polymerase 2 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Poly Polymerase 2 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Poly Polymerase 2 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Poly Polymerase 2 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Poly Polymerase 2 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Poly Polymerase 2 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Poly Polymerase 2 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Poly Polymerase 2 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Poly Polymerase 2 Sales Market Share by Application (2015-2020)
Table 72. AbbVie Inc Corporation Information
Table 73. AbbVie Inc Description and Major Businesses
Table 74. AbbVie Inc Poly Polymerase 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. AbbVie Inc Product
Table 76. AbbVie Inc Recent Development
Table 77. AstraZeneca Plc Corporation Information
Table 78. AstraZeneca Plc Description and Major Businesses
Table 79. AstraZeneca Plc Poly Polymerase 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. AstraZeneca Plc Product
Table 81. AstraZeneca Plc Recent Development
Table 82. BeiGene Ltd Corporation Information
Table 83. BeiGene Ltd Description and Major Businesses
Table 84. BeiGene Ltd Poly Polymerase 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. BeiGene Ltd Product
Table 86. BeiGene Ltd Recent Development
Table 87. Clovis Oncology Inc Corporation Information
Table 88. Clovis Oncology Inc Description and Major Businesses
Table 89. Clovis Oncology Inc Poly Polymerase 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Clovis Oncology Inc Product
Table 91. Clovis Oncology Inc Recent Development
Table 92. Eisai Corporation Information
Table 93. Eisai Description and Major Businesses
Table 94. Eisai Poly Polymerase 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Eisai Product
Table 96. Eisai Recent Development
Table 97. Ildong Pharmaceutical Co Ltd Corporation Information
Table 98. Ildong Pharmaceutical Co Ltd Description and Major Businesses
Table 99. Ildong Pharmaceutical Co Ltd Poly Polymerase 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Ildong Pharmaceutical Co Ltd Product
Table 101. Ildong Pharmaceutical Co Ltd Recent Development
Table 102. Jiangsu Hengrui Medicine Co Ltd Corporation Information
Table 103. Jiangsu Hengrui Medicine Co Ltd Description and Major Businesses
Table 104. Jiangsu Hengrui Medicine Co Ltd Poly Polymerase 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Jiangsu Hengrui Medicine Co Ltd Product
Table 106. Jiangsu Hengrui Medicine Co Ltd Recent Development
Table 107. Shanghai Acebright Pharmaceuticals Group Co Ltd Corporation Information
Table 108. Shanghai Acebright Pharmaceuticals Group Co Ltd Description and Major Businesses
Table 109. Shanghai Acebright Pharmaceuticals Group Co Ltd Poly Polymerase 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Shanghai Acebright Pharmaceuticals Group Co Ltd Product
Table 111. Shanghai Acebright Pharmaceuticals Group Co Ltd Recent Development
Table 112. Tesaro Inc Corporation Information
Table 113. Tesaro Inc Description and Major Businesses
Table 114. Tesaro Inc Poly Polymerase 2 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Tesaro Inc Product
Table 116. Tesaro Inc Recent Development
Table 117. Global Poly Polymerase 2 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 118. Global Poly Polymerase 2 Sales Market Share Forecast by Regions (2021-2026)
Table 119. Global Poly Polymerase 2 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 120. Global Poly Polymerase 2 Revenue Market Share Forecast by Regions (2021-2026)
Table 121. North America: Poly Polymerase 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 122. North America: Poly Polymerase 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Europe: Poly Polymerase 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 124. Europe: Poly Polymerase 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Asia Pacific: Poly Polymerase 2 Sales Forecast by Region (2021-2026) (K Pcs)
Table 126. Asia Pacific: Poly Polymerase 2 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 127. Latin America: Poly Polymerase 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. Latin America: Poly Polymerase 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Middle East and Africa: Poly Polymerase 2 Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Middle East and Africa: Poly Polymerase 2 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key Poly Polymerase 2 Players
Table 135. Poly Polymerase 2 Customers List
Table 136. Poly Polymerase 2 Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Poly Polymerase 2 Product Picture
Figure 2. Global Poly Polymerase 2 Sales Market Share by Type in 2020 & 2026
Figure 3. BGB-290 Product Picture
Figure 4. AZ-0108 Product Picture
Figure 5. CK-102 Product Picture
Figure 6. NOV-1401 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Poly Polymerase 2 Sales Market Share by Application in 2020 & 2026
Figure 9. Peritoneal Cancer
Figure 10. B-Cell Chronic Lymphocytic Leukemia
Figure 11. Laryngeal Cancer
Figure 12. Others
Figure 13. Poly Polymerase 2 Report Years Considered
Figure 14. Global Poly Polymerase 2 Market Size 2015-2026 (US$ Million)
Figure 15. Global Poly Polymerase 2 Sales 2015-2026 (K Pcs)
Figure 16. Global Poly Polymerase 2 Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Poly Polymerase 2 Sales Market Share by Region (2015-2020)
Figure 18. Global Poly Polymerase 2 Sales Market Share by Region in 2019
Figure 19. Global Poly Polymerase 2 Revenue Market Share by Region (2015-2020)
Figure 20. Global Poly Polymerase 2 Revenue Market Share by Region in 2019
Figure 21. Global Poly Polymerase 2 Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Poly Polymerase 2 Revenue in 2019
Figure 23. Poly Polymerase 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Poly Polymerase 2 Sales Market Share by Type (2015-2020)
Figure 25. Global Poly Polymerase 2 Sales Market Share by Type in 2019
Figure 26. Global Poly Polymerase 2 Revenue Market Share by Type (2015-2020)
Figure 27. Global Poly Polymerase 2 Revenue Market Share by Type in 2019
Figure 28. Global Poly Polymerase 2 Market Share by Price Range (2015-2020)
Figure 29. Global Poly Polymerase 2 Sales Market Share by Application (2015-2020)
Figure 30. Global Poly Polymerase 2 Sales Market Share by Application in 2019
Figure 31. Global Poly Polymerase 2 Revenue Market Share by Application (2015-2020)
Figure 32. Global Poly Polymerase 2 Revenue Market Share by Application in 2019
Figure 33. North America Poly Polymerase 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Poly Polymerase 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Poly Polymerase 2 Sales Market Share by Country in 2019
Figure 36. North America Poly Polymerase 2 Revenue Market Share by Country in 2019
Figure 37. U.S. Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Poly Polymerase 2 Market Share by Type in 2019
Figure 42. North America Poly Polymerase 2 Market Share by Application in 2019
Figure 43. Europe Poly Polymerase 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Poly Polymerase 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Poly Polymerase 2 Sales Market Share by Country in 2019
Figure 46. Europe Poly Polymerase 2 Revenue Market Share by Country in 2019
Figure 47. Germany Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Poly Polymerase 2 Market Share by Type in 2019
Figure 58. Europe Poly Polymerase 2 Market Share by Application in 2019
Figure 59. Asia Pacific Poly Polymerase 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Poly Polymerase 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Poly Polymerase 2 Sales Market Share by Region in 2019
Figure 62. Asia Pacific Poly Polymerase 2 Revenue Market Share by Region in 2019
Figure 63. China Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Poly Polymerase 2 Market Share by Type in 2019
Figure 86. Asia Pacific Poly Polymerase 2 Market Share by Application in 2019
Figure 87. Latin America Poly Polymerase 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Poly Polymerase 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Poly Polymerase 2 Sales Market Share by Country in 2019
Figure 90. Latin America Poly Polymerase 2 Revenue Market Share by Country in 2019
Figure 91. Mexico Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Poly Polymerase 2 Market Share by Type in 2019
Figure 98. Latin America Poly Polymerase 2 Market Share by Application in 2019
Figure 99. Middle East and Africa Poly Polymerase 2 Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Poly Polymerase 2 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Poly Polymerase 2 Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Poly Polymerase 2 Revenue Market Share by Country in 2019
Figure 103. Turkey Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Poly Polymerase 2 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Poly Polymerase 2 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Poly Polymerase 2 Market Share by Type in 2019
Figure 110. Middle East and Africa Poly Polymerase 2 Market Share by Application in 2019
Figure 111. North America Poly Polymerase 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Poly Polymerase 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Poly Polymerase 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Poly Polymerase 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Poly Polymerase 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Poly Polymerase 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Poly Polymerase 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Poly Polymerase 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Poly Polymerase 2 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Poly Polymerase 2 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed